Analyst Geoff Meacham downgraded the biotech name to sell.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
Stocks posted back-to-back losses on Tuesday as Treasury yields continued their rise.
Most traders are looking at Micron into earnings. But don’t count out Nike
Micron reports Wednesday after the bell and Nike results are out Thursday after the close.
IPO postponements are accelerating in third quarter, even beyond Oura
It’s been a strong year for IPOs. But now, more companies are deciding to stay on the sidelines.
Get paid even more on your cash holdings with this strategy
Income-seeking investors can pick up a little more interest on their cash by laddering T-bills.
I sold UnitedHealth shares when the business stumbled. Here’s why I’m buying again
UnitedHealth is showing signs of improvement after higher medical costs pressured earnings and margins, and Kevin Simpson is starting to buy the stock again.
Micron earnings this week could test whether the memory boom has more room to run
Micron is generating margins that would have been almost unthinkable in previous memory cycles, while the stock still trades at a low earnings multiple.
Here are Tuesday’s biggest analyst calls: Nvidia, SpaceX, Apple, Netflix, Kroger, AutoZone & more
Here are Tuesday’s biggest calls on Wall Street.
Higher rates are wreaking havoc on these two ETFs. Traders see one bouncing back
The relentless surge in rates is breaking the back of two key macro trades that had been holding firm.
Netflix has sold off in September. Deutsche Bank says buy the dip
Analyst Bryan Kraft upgraded the streaming giant to buy from hold.